VAERS reports by lot

Pfizer COVID-19 lot FR2583: VAERS reports

722 VAERS reports list lot FR2583 as a Pfizer COVID-19 vaccine, received between 2022-08-17 and 2024-05-22. Data: VAERS public files through 31 December 2024 (site extract 2026-07-04).

Read this first. VAERS accepts reports from anyone, and a report does not establish that the vaccine caused the event. A lot's report count mostly reflects how many doses it contained, when it was used and who received it; no administered-dose counts are published for this lot, so counts are not rates and cannot rank lots against each other. Lot numbers in VAERS reports are typed by reporters and are sometimes wrong.
722
Reports
2%
Marked serious
0
With a death outcome
15
Months with reports

Symptom categories in these reports

A report can mention several categories, so the counts add up to more than the number of reports.

CategoryCount%
Neurological3817%
Cardiac / Cardiovascular3817%
General / Systemic (non-local)2913%
Gastrointestinal2813%
Musculoskeletal2612%
Allergic / Anaphylactic157%
Dermatological (non-injection-site)146%
Respiratory125%
Injection-site / Local reaction115%
Autoimmune / Immune-mediated94%
Thrombotic / Hematological21%
Psychiatric / Neuropsychiatric10%

Where reports came from

U.S. state of the reporter, where given (top 12).

Massachusetts147
Virginia67
California57
Oregon41
Pennsylvania35
Ohio35
Illinois31
Florida21
Georgia18
Texas14
Idaho13
Wisconsin11

Reports by month received

2022-083
2022-0930
2022-10137
2022-11220
2022-12176
2023-0158
2023-0211
2023-037
2023-0427
2023-0536
2023-0610
2023-074
2024-011
2024-021
2024-051

Products recorded with this lot

Manufacturer and product as reported in VAERS. Reports listing the lot under more than one product are counted once.

Related

Source: VAERS public data (CDC/FDA), grouped by manufacturer and lot by the Open Source Medicine Foundation; extract 2026-07-04 16:35 UTC. Not medical advice. Report errors via contact.